Resmed RSMDF
NYSE RSMDF
$22.61 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Resmed (RSMDF) Other Non-Current Assets (2010 - 2026)

Resmed's (RSMDF) quarterly Other Non-Current Assets came in at $457.4 million in Q2 2026, up 146.12% on a YoY basis from $185.8 million in Q2 2025, and up 117.04% quarter-over-quarter from $210.7 million in Q1 2026.

Analysis

Resmed (RSMDF) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Resmed (RSMDF) has reported Other Non-Current Assets for 17 consecutive years, with $457.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Assets rose 146.12% year-over-year to $457.4 million; the trailing twelve-month figure through Jun 2026 stood at $457.4 million (up 146.12% YoY), and the FY2026 full-year result was $457.4 million, up 146.12% from the prior year.
  • Other Non-Current Assets rose to $457.4 million in Q2 2026 per RSMDF's latest filing, from $210.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $457.4 million in Q2 2026 and bottomed at $169.4 million in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $237.9 million across 5 years, with a median of $235.4 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets plunged 37.03% in 2025, then jumped 146.12% in 2026.
  • Over 5 years, Other Non-Current Assets stood at $260.2 million in 2022, then advanced by 6.02% to $275.8 million in 2023, then sank by 34.31% to $181.2 million in 2024, then rose by 7.01% to $193.9 million in 2025, then jumped by 135.91% to $457.4 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $457.4 million, $210.7 million, and $193.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 184.57 Bn 178.97 Bn 7.27 Bn -
2 Intuitive Surgical 124.13 Bn 118.91 Bn 1.96 Bn -
3 Medtronic 118.29 Bn 109.47 Bn 6.34 Bn 4.32 Bn
4 Stryker 104.60 Bn 101.12 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 66.50 Bn 65.97 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.72 Bn 45.46 Bn 1.35 Bn 616.40 Mn
7 Alcon 33.97 Bn 32.51 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.23 Bn 30.29 Bn 830.00 Mn 273.70 Mn
9 Steris 21.16 Bn 20.68 Bn 684.20 Mn 215.10 Mn
10 Resmed 3.54 Bn 2.07 Bn 861.22 Mn 457.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 457.39 Mn
Mar 31, 2026 210.73 Mn
Dec 31, 2025 193.88 Mn
Sep 30, 2025 189.84 Mn
Jun 30, 2025 185.84 Mn
Mar 31, 2025 174.63 Mn
Dec 31, 2024 181.18 Mn
Sep 30, 2024 278.85 Mn
Jun 30, 2024 284.00 Mn
Mar 31, 2024 277.33 Mn
Dec 31, 2023 275.82 Mn
Sep 30, 2023 265.11 Mn
Jun 30, 2023 262.45 Mn
Mar 31, 2023 270.87 Mn
Dec 31, 2022 260.16 Mn
Sep 30, 2022 173.43 Mn
Jun 30, 2022 171.75 Mn
Mar 31, 2022 169.40 Mn
Dec 31, 2021 165.54 Mn
Sep 30, 2021 162.99 Mn